Recursion is advancing REC-617, a promising reversible, non-covalent CDK7 inhibitor, showing potential in treating advanced solid tumors with positive interim phase 1 data. Read more here.

Is DOGE a cybersecurity crisis? Musk inserts himself into OpenAI’s transition, Vance wants less international tech regulation ...

When the director of a small regional science nonprofit sat down last week to pay a few bills, she got a shock. In the fall, ...

On Tuesday, software company Inuvo launched IntentKey, an audience insights platform that creates real-time models for targeting ads.

The way we seek and process information has experienced a significant transformation over the past few years. Advances in ...

Staff have been asked to look at the title or abstract of the research proposal, checking whether any of the worrisome terms ...

Discover how Natural Language Processing (NLP) is transforming AI-driven solutions, from chatbots to sentiment analysis. In ...

Tech giant OpenAI has unveiled a pay-for-access tool called ‘deep research’, which synthesizes information from dozens or ...

Some of the terms that are getting flagged are particularly eyebrow-raising in light of the Nazi salutes that Trump ...

National Science Foundation staff have been combing through thousands of active science research projects, alongside a list of keywords, to determine if they include activities that violate Trump’s ...

With AI creating a need for knowledge engineering, information science (as we used to call it) has come full circle. It comes ...

Data shows that AI Overviews is answering more complex queries by up to 100% and is rewarding context appropriate content ...